FDA panel gives nod to Hologic tomosynthesis PMA

Sep 23, 2010

An advisory panel of the U.S. Food and Drug Administration today unanimously approved a premarket approval (PMA) application from Hologic for a digital breast tomosynthesis (DBT) system. If the FDA signs off on the final PMA, Hologic will be the first vendor to sell a DBT system on the U.S. market.

Click here to read the rest of the article.

Latest in Breast
Mammogram Dense Breasts Cropped
Missed previous mammography screening linked to worse disease outcomes
October 3, 2025
2025 10 02 Shahrvini Ai Vs Radiologist False Positives Thumbnail
False-positive DBT findings differ between AI, radiologists
October 2, 2025
Mammography Breast Ipad Patient 400
Women who skip first mammogram more likely to die of breast cancer
September 24, 2025
Breast Tomosynthesis Digital 400 (1)
Study finds AI not cost-effective for breast cancer screening
September 24, 2025
Related Stories
Hologic Logo
Brachytherapy Seeds & Systems
Hologic EU
2010 09 07 11 17 05 930 Durictalk Thumb
Ultrasound
Whole-breast ultrasound tomography shows promise
2010 08 19 12 35 41 749 Destounis thumb 08 10 Sm
Breast
Breast CAD helps find lobular carcinoma in situ lesions
2009 06 23 14 37 33 976 Second Opinion Am
Breast
The breast screening hullabaloo: Where are we today?
More in Breast
Missed previous mammography screening linked to worse disease outcomes
By Amerigo Allegretto
Researchers found that women who did not attend their previous screening had larger tumors and poorer disease-specific survival.
October 3, 2025
Mammogram Dense Breasts Cropped
False-positive DBT findings differ between AI, radiologists
By Amerigo Allegretto
False-positive DBT findings differed between AI and radiologists in population-based breast cancer screening.
October 2, 2025
2025 10 02 Shahrvini Ai Vs Radiologist False Positives Thumbnail
Women who skip first mammogram more likely to die of breast cancer
By Amerigo Allegretto
Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.
September 24, 2025
Mammography Breast Ipad Patient 400
Study finds AI not cost-effective for breast cancer screening
By Amerigo Allegretto
AI is not cost-effective for breast cancer screening, even with reductions in mortality, false-positive cases, and false-negative cases, according to new research.
September 24, 2025
Breast Tomosynthesis Digital 400 (1)
Adding MBI to DBT finds more breast cancers
By Amerigo Allegretto
Adding molecular breast imaging (MBI) to DBT screening leads to more invasive cancers detected in women with dense breasts.
September 23, 2025
Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).
Echogenic rind on breast ultrasound holds diagnostic significance
By Amerigo Allegretto
An echogenic rind on breast ultrasound could spell malignancy for suspicious lesions.
September 17, 2025
Diagnostic transverse ultrasound image of the left breast in a 64-year-old woman shows irregular hypoechoic nonparallel mass with indistinct margins corresponding to palpable finding, assessed as BI-RADS category 4. Both readers assessed mass as having associated echogenic rind with complete circumferential extent (arrowheads). Ultrasound-guided biopsy of mass yielded diagnosis of invasive ductal carcinoma (intermediate grade, luminal A molecular subtype, no lymphovascular invasion).
DBT plus synthesized mammo leads to less false-positive recalls
By Amerigo Allegretto
A subanalysis of the TOSYMA trial found that DBT plus synthesized mammography leads to lower false-positive recall rates compared to digital mammography.
September 16, 2025
Breast Tomosynthesis Digital Social
AI interpretation leads to high NPV, recall rates in breast imaging
By Amerigo Allegretto
In a new study, an AI system reached near-perfect negative predictive value (NPV) in breast imaging but almost doubled the recall rate.
September 3, 2025
2025 09 03 Ajr Ai Breast Images Thumbnail
Spain’s Valencian Community selects Lunit AI software for breast screening program
By AuntMinnie.com staff writers
The Valencian Community, Spain’s third-largest healthcare region, has selected Lunit’s AI software for its breast cancer screening program.
September 2, 2025
Breast Mammo Computer 400
Experts issue appropriate use criteria for molecular breast imaging
By Will Morton
The criteria offer use scenarios for technetium-99 (Tc-99m) sestamibi-based gamma camera imaging of the breast.
August 27, 2025
Breast Cancer
MRI model predicts breast tumor shrinkage patterns
By Amerigo Allegretto
An MRI model based on tumor microbiome images can predict breast tumor shrinkage patterns after neoadjuvant therapy.
August 26, 2025
2025 08 26 Radiology Mri Tumor Shrinkage Model Thumbnail
Calidar launches study of novel x-ray diffraction mammography system
By AuntMinnie.com staff writers
Diagnostic imaging startup Calidar has initiated the first in-human study of its x-ray diffraction 4D Mammography system.
August 19, 2025
Breast Mammo Computer 400
Page 1 of 574
Next Page